Literature DB >> 19474712

Malnutrition and wasting in renal disease.

Maurizio Muscaritoli1, Alessio Molfino, Maria Rosa Bollea, Filippo Rossi Fanelli.   

Abstract

PURPOSE OF REVIEW: Malnutrition and accelerated catabolism frequently complicate chronic kidney disease and end-stage renal disease. This review provides an update on the recent advances in the understanding of the mechanisms underlying protein-energy wasting, both in experimental and human models, and on the currently available therapeutic approaches. RECENT
FINDINGS: Increased levels of circulating cytokines, metabolic acidosis, oxidative stress and insulin resistance all appear to be variably implicated in muscle protein breakdown during end-stage renal disease and dialysis. The individual role of each component in the pathogenesis of chronic kidney disease-related wasting is still unclear, but recent clinical data show a positive relationship between inflammation and muscle protein catabolism as a major contributing factor.
SUMMARY: The basis for appropriate therapeutic approaches to protein-energy wasting in chronic kidney disease and end-stage renal disease relies entirely on the understanding of its pathophysiology. Our knowledge of the pathogenesis of malnutrition and hypercatabolism in renal disease is still limited and mostly based on experimental data, but the currently available evidence suggests that multimodal preventive and therapeutic strategies should be entertained.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474712     DOI: 10.1097/MCO.0b013e32832c7ae1

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  21 in total

Review 1.  Acetylation and deacetylation--novel factors in muscle wasting.

Authors:  Nima Alamdari; Zaira Aversa; Estibaliz Castillero; Per-Olof Hasselgren
Journal:  Metabolism       Date:  2012-05-22       Impact factor: 8.694

2.  Protein-energy wasting, as well as overweight and obesity, is a long-term risk factor for mortality in chronic hemodialysis patients.

Authors:  Liviu Segall; Mihaela Moscalu; Simona Hogaş; Irina Mititiuc; Ionuţ Nistor; Gabriel Veisa; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2014-01-29       Impact factor: 2.370

3.  Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.

Authors:  Garland A Campbell; James T Patrie; Bruce D Gaylinn; Michael O Thorner; Warren K Bolton
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

4.  Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients.

Authors:  Hirokazu Honda; Masashi Ueda; Shiho Kojima; Shinichi Mashiba; Hiroki Suzuki; Nozomu Hosaka; Yuki Hirai; Mari Nakamura; Hisako Nagai; Noriyuki Kato; Masanori Mukai; Makoto Watanabe; Keiko Takahashi; Kanji Shishido; Tadao Akizawa
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-15       Impact factor: 8.237

5.  Nutrition support among critically ill children with AKI.

Authors:  Ursula G Kyle; Ayse Akcan-Arikan; Renán A Orellana; Jorge A Coss-Bu
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-04       Impact factor: 8.237

Review 6.  Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?

Authors:  Mark D DeBoer
Journal:  Mol Cell Endocrinol       Date:  2011-02-25       Impact factor: 4.102

Review 7.  Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15.

Authors:  V W W Tsai; S Lin; D A Brown; A Salis; S N Breit
Journal:  Int J Obes (Lond)       Date:  2015-12-01       Impact factor: 5.095

8.  Prealbumin is associated with visceral fat mass in patients receiving hemodialysis.

Authors:  Alessio Molfino; Steven B Heymsfield; Fansan Zhu; Peter Kotanko; Nathan W Levin; Tjien Dwyer; George A Kaysen
Journal:  J Ren Nutr       Date:  2013-04-24       Impact factor: 3.655

9.  Chronic renal failure, cachexia, and ghrelin.

Authors:  A Laviano; Z Krznaric; K Sanchez-Lara; I Preziosa; A Cascino; F Rossi Fanelli
Journal:  Int J Pept       Date:  2010-02-04

10.  Comparison of bioimpedance and dual-energy x-ray absorptiometry for measurement of fat mass in hemodialysis patients.

Authors:  Alessio Molfino; Burl R Don; George A Kaysen
Journal:  Nephron Clin Pract       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.